Atlas Trials

Stage IIIB Gastric Cancer

19 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Stage IIIB Gastric Cancer

RecordFirmDate
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer (NCT03154190)Stanford University2017-08-08
Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney Dysfunction (NCT02567396)National Cancer Institute (NCI)2016-06-01
Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery (NCT02511821)City of Hope Medical Center2015-07-22
C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer (NCT02344810)Eastern Cooperative Oncology Group2015-03-06
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer (NCT02366819)University of Chicago2014-12-11
Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer (NCT02333188)University of Chicago2014-12-01
64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer (NCT01939275)City of Hope Medical Center2014-11-19
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers (NCT01846520)City of Hope Medical Center2013-10-01
Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery (NCT01612546)City of Hope Medical Center2012-11-01
Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer (NCT01212822)Fox Chase Cancer Center2011-04-27
Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer (NCT01178944)Roswell Park Cancer Institute2010-09-01
Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer (NCT00982592)National Cancer Institute (NCI)2009-09-01
Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery (NCT00991952)National Cancer Institute (NCI)2009-09-01
Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (NCT00084604)National Cancer Institute (NCI)2004-04-01
Phase II Study of Oxaliplatin, Irinotecan, and Capecitabine in Advanced Gastric/Gastroesophageal Junction Carcinoma (NCT00084617)National Cancer Institute (NCI)2004-03-01

Track Stage IIIB Gastric Cancer automatically

Every clearance here is in the API, with alerts when new ones post.